Hangzhou Aier Eye Hospital, Hangzhou, 310000, Zhejiang, China.
Sir Run Run Shaw Hospital Hangzhou, Hangzhou, 310000, China.
BMC Ophthalmol. 2023 Dec 11;23(1):503. doi: 10.1186/s12886-023-03234-3.
Accumulated evidence suggests that M2-like polarized macrophages plays an important role in reducing inflammation, promoting and accelerating wound healing process and tissue repair. Thus, M2-like TAMs (Tumour-associated macrophages) was an appealing target for therapy intervention.
Flow cytometry and RT-PCR assay were used to detect the polarization of macrophages induced by Medrysone, and the rat corneal mechanical injury model was established to evaluate the efficacy of Medrysone in cornel repair.
Here we found that Medrysone enhanced IL-4 induced M2 polarization of macrophages, as illustrated by increased expression of CD206, up-regulation of M2 marker mRNAs. Medrysone promoted VEGF and CCL2 secretion in IL-4 induced M2-like polarization. IL-4 triggered STAT6 activation was further enhanced by Medrysone and silencing of STAT6 partially abrogated the stimulatory effect of Medrysone. Medrysone improved migration-promoting feature of M2-like macrophages, as indicated by increased migration of endothelial cells. Further, Medrysone promoted corneal injury repair by inducing M2 polarization of macrophages in vivo.
Our study suggest that Medrysone promotes corneal injury repair by inducing the M2 polarization of macrophages, providing a theoretical basis for the application of Medrysone in the treatment of corneal injury.
有大量证据表明,M2 样极化的巨噬细胞在减轻炎症、促进和加速伤口愈合过程和组织修复方面发挥着重要作用。因此,M2 样 TAMs(肿瘤相关巨噬细胞)是治疗干预的一个有吸引力的靶点。
采用流式细胞术和 RT-PCR 检测方法检测 Medrysone 诱导的巨噬细胞极化,建立大鼠角膜机械损伤模型,评价 Medrysone 在角膜修复中的疗效。
我们发现 Medrysone 增强了 IL-4 诱导的 M2 极化的巨噬细胞,表现为 CD206 表达增加,M2 标志物 mRNAs 的上调。Medrysone 促进了 IL-4 诱导的 M2 样极化中 VEGF 和 CCL2 的分泌。IL-4 触发的 STAT6 激活被 Medrysone 进一步增强,而 STAT6 的沉默部分阻断了 Medrysone 的刺激作用。Medrysone 增强了 M2 样巨噬细胞的迁移促进特征,表现为内皮细胞的迁移增加。此外,Medrysone 通过诱导体内 M2 样巨噬细胞的极化促进了角膜损伤的修复。
本研究表明,Medrysone 通过诱导巨噬细胞的 M2 极化促进角膜损伤修复,为 Medrysone 在角膜损伤治疗中的应用提供了理论依据。